While there are several success stories where technology has helped level the playing field and brought economic opportunities to vulnerable communities in India, the question remains: Will technology help advance gender equality, or will it instead fuel a growing gender-digital divide?
CGD Policy Blogs
Innovation is a critical tool in the global fight against disease—especially for tuberculosis (TB), an infectious disease that primarily affects the poor and vulnerable and ranks among the top 10 causes of death in the world.
For the past 18 months, CGD has incubated the Energy for Growth Hub, a new initiative dedicated to the idea that energy should be an enabler, not a barrier, to human potential. The Hub is now ready to fly on its own.
Matti Kohonen of Christian Aid holds out the enticing prospect that African countries could collect an additional 1.5 percent of gross domestic product in tax if only big multinationals would stop dodging. The problem is that this estimate is (still) based on wishful thinking. Multinational corporations should pay tax, but the scale of potential revenues depend on underlying levels of investment and profitability in a country.
In announcing that refugees will be able to open bank accounts and participate in the formal economy, Imran Khan’s government has taken an important first step towards ensuring that refugees can access the formal labor market in Pakistan. Here we outline how to ensure the potential benefits are realized.
In their recently released 2019 annual letter, Bill and Melinda Gates argue that data can be sexist. Missing or inaccurate data on women and girls can block their progress and that of society and economic development at large, they state, since robust gender data has the power to encourage change to achieve greater gender equality.
The US Supreme Court decided, in a ruling on Jam v. International Finance Corporation (IFC), that the IFC can be sued in US courts.
Concern about relatively low development finance institution (DFI) mobilization ratios (dollars of private finance mobilized per dollar of DFI’s own commitments) is drawing attention to the product mix in DFI operations.
In many developing countries health supply chains function poorly, resulting in frequent stockouts and many substandard and even falsified medications—which undermine treatment effectiveness and raise the risk of antimicrobial resistance.